Price target
Based on analysts projections #NSTG is expected to experience a positive growth trajectory over the next year.
The current average NSTG price target, as estimated by these analysts, is $21.50.
The predictions for the future NSTG stock price range from a low of $15.00 to a high of $28.00, highlighting the variability of market expectations for NSTG.
It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.
NSTG stock forecasts by analyst
| Analyst / firm | Date | Rating | Price target | Price when posted |
|---|---|---|---|---|
| UBS | February 2, 2023 | Buy | 15.00 | 11.99 |
| Morgan Stanley | August 8, 2022 | Buy | 28.00 | 15.50 |
NanoString Technologies (NSTG) Fundamentals Checker
Financial metrics are used to evaluate financial stability which helps analysts determine if NanoString Technologies is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.
Buy
Financial Scores
Updated on: 07/12/2023
Altman Z-Score: -5.5
Piotroski Score: 3.0
ESG Score
Updated on: 07/12/2023
Environmental: 57.2
Social: 58.2
Governance: 56.9
Financial Health
Updated on: 07/12/2023
DCF: Strong Buy
ROE: Strong Sell
ROA: Sell
Debt to equity ratio: Strong Buy
Price to earnings ratio: Sell
Price to book ratio: Strong Buy
NSTG Discounted Cash Flow
Updated on: 07/12/2023
$0.000
Discounted Cash Flow Value
$0.000
Current Price
NSTG Revenues by Segment
Updated on: 07/12/2023
Revenue from Contract with Customer, Excluding Assessed Tax
NSTG Revenues by Region
Updated on: 07/12/2023
NSTG Notes Due
Updated on: 07/12/2023
| CIK | Exchange | Title |
|---|
There are no data to display
5:00 PM (UTC)
Date:05 December, 2023
0
Twitter Sentiment
0.3
Stocktwits Sentiment
Twitter Posts: 0 Twitter Comments: 0 Twitter Likes: 0 Twitter Impressions: 0
Stocktwits Posts: 1 Stocktwits Comments: 1 Stocktwits Likes: 0 Stocktwits Impressions: 1
3:00 PM (UTC)
Date:05 December, 2023
0
Twitter Sentiment
0.6
Stocktwits Sentiment
Twitter Posts: 0 Twitter Comments: 0 Twitter Likes: 0 Twitter Impressions: 0
Stocktwits Posts: 1 Stocktwits Comments: 0 Stocktwits Likes: 1 Stocktwits Impressions: 2
1:00 AM (UTC)
Date:04 December, 2023
0
Twitter Sentiment
0.5
Stocktwits Sentiment
Twitter Posts: 0 Twitter Comments: 0 Twitter Likes: 0 Twitter Impressions: 0
Stocktwits Posts: 1 Stocktwits Comments: 0 Stocktwits Likes: 2 Stocktwits Impressions: 487
11:00 AM (UTC)
Date:03 December, 2023
0
Twitter Sentiment
0.5125
Stocktwits Sentiment
Twitter Posts: 0 Twitter Comments: 0 Twitter Likes: 0 Twitter Impressions: 0
Stocktwits Posts: 1 Stocktwits Comments: 0 Stocktwits Likes: 0 Stocktwits Impressions: 13,651
NanoString Technologies: A Powerful Stock Forecast in Biotech for Innovative Diagnostic Solutions
NanoString Technologies (NSTG) is a major company under the Medical Instruments & Supplies sector that specializes in biotechnology research and development. The firm has established itself as a pioneer in molecular diagnostics through the development of advanced technology platforms capable of detecting alterations in genes and proteins related to various diseases. NanoString's unique digital decoding technology allows for precise and...
The stock forecast of NanoString has been on an upward trajectory despite many challenges in the industry recently. Experts attribute the growth to remarkable financial results by the company alongside steady investments in aggressive growth initiatives. In 2023, revenue increased by almost 18%, reaching $133 million.
By staying on top of investors' minds with innovative diagnostic technologies, acquisitions, new market penetrations, strategic partnerships, and early-stage research collaborations paved the way to unprecedented success for NanoString Technologies. The company's commitment to uncovering new biomarkers for disease diagnosis and prognostication positions them as one of the best prospects in their field today.
Additionally, NanoString acquired two noteworthy firms: GeoMx Digital Spatial Profiler from Veracyte ($700 million deal), expanding their capacity for genomic analysis and immune profiling; and QIAGEN's dermatology franchise assets - providing access to a wide range of standard-of-care assays for oncology patients.
There is immense growth potential still visible pervading NanoString Technologies shares due to its robust business outlook moving forward. It remains an attractive investment prospect among biotech sector giants — a testament that continuous innovation and business versatility can triumph over pandemic turmoil or other unforeseen headwinds.
In conclusion, NanoString Technologies is a highly recommended stock candidate due to its cutting-edge solutions intended for groundbreaking medical treatment benefits. Their pioneering advancements in the field of molecular diagnostics demonstrate a highly innovative outlook with its leadership position assured for years to come. With this, investors are considering NanoString Technologies as a sound financial decision at present because of their impressive financial results, growing demand, and dynamic collaborations ultimately leading to sustained growth and astounding Stock Forecast outlook.">Read more
The stock forecast of NanoString has been on an upward trajectory despite many challenges in the industry recently. Experts attribute the growth to remarkable financial results by the company alongside steady investments in aggressive growth initiatives. In 2023, revenue increased by almost 18%, reaching $133 million.
By staying on top of investors' minds with innovative diagnostic technologies, acquisitions, new market penetrations, strategic partnerships, and early-stage research collaborations paved the way to unprecedented success for NanoString Technologies. The company's commitment to uncovering new biomarkers for disease diagnosis and prognostication positions them as one of the best prospects in their field today.
Additionally, NanoString acquired two noteworthy firms: GeoMx Digital Spatial Profiler from Veracyte ($700 million deal), expanding their capacity for genomic analysis and immune profiling; and QIAGEN's dermatology franchise assets - providing access to a wide range of standard-of-care assays for oncology patients.
There is immense growth potential still visible pervading NanoString Technologies shares due to its robust business outlook moving forward. It remains an attractive investment prospect among biotech sector giants — a testament that continuous innovation and business versatility can triumph over pandemic turmoil or other unforeseen headwinds.
In conclusion, NanoString Technologies is a highly recommended stock candidate due to its cutting-edge solutions intended for groundbreaking medical treatment benefits. Their pioneering advancements in the field of molecular diagnostics demonstrate a highly innovative outlook with its leadership position assured for years to come. With this, investors are considering NanoString Technologies as a sound financial decision at present because of their impressive financial results, growing demand, and dynamic collaborations ultimately leading to sustained growth and astounding Stock Forecast outlook.">Read more
NanoString Technologies: A Promising Stock Prediction in the Medical Instrument and Supplies Sector
The medical instruments and supplies sector is a crucial part of the healthcare industry, providing healthcare professionals with necessary tools to diagnose, treat, and prevent illness. From imaging equipment to surgical instruments, this sector's products play a vital role in saving lives and promoting good health. As investors search for opportunities in the stock market, medical instrument and supply companies...
Furthermore, analyst Swayampakula Ramakanth predicts that NSTG could potentially hit $100 per share by year-end 2023. Considering that their current trading price is around $73, there remains significant upside potential; however CNBC Markets' estimates are less optimistic, with a median estimate of $80 per share.
The future of NanoString Technologies looks promising, as it continues to focus on developing innovative products and expanding partnerships with major players in the industry. As investors look for opportunities in the medical instruments and supplies market, NSTG offers a compelling prospect due to their impressive track record and optimistic stock predictions. So, if you're on the lookout for an investment in this sector, set your sights on NanoString Technologies.">Read more
Furthermore, analyst Swayampakula Ramakanth predicts that NSTG could potentially hit $100 per share by year-end 2023. Considering that their current trading price is around $73, there remains significant upside potential; however CNBC Markets' estimates are less optimistic, with a median estimate of $80 per share.
The future of NanoString Technologies looks promising, as it continues to focus on developing innovative products and expanding partnerships with major players in the industry. As investors look for opportunities in the medical instruments and supplies market, NSTG offers a compelling prospect due to their impressive track record and optimistic stock predictions. So, if you're on the lookout for an investment in this sector, set your sights on NanoString Technologies.">Read more
NanoString Technologies (NSTG) Social Sentiments
Monitoring bullish and bearish sentiments towards NanoString Technologies on Twitter and Stocktwits could help to forecast an upward or downward trend in NanoString Technologies stock price.